News
The system for compensating people injured by vaccines needs significant reform. But the health secretary could alter it in ...
The recent portfolio rebalance increased FDL's risk and volatility, with 55% concentration in its top 10 holdings. Read why I ...
Women with advanced form womb cancer have been given fresh hope after a new treatment was given the green light for ...
7h
Zacks Investment Research on MSNMerck's Narrowed 2025 Sales View: What it Means After Q2 Results?Merck MRK announced mixed second-quarter results last month. The company beat estimates for earnings while meeting the same ...
9h
Zacks Investment Research on MSNMerck Stock Down 4% Since Q2 Results: How to Play the StockMerck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...
IO Biotech said on Monday its experimental cancer vaccine, in combination with Merck's Keytruda, showed improvement in a late ...
IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...
Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
Dermatologist Dr. Julia Carroll shares simple tips for checking your skin at home to spot potential issues. Learn how easy it is to monitor changes and why it’s important for your health. The Weather ...
Novo Nordisk, GSK and others need to replenish their pipelines to replace drugs coming off patent. In the past, buying a promising biotech required paying a 100% premium. But high interest rates and ...
Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo vs sunitinib.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results